Brawn Biotech has informed that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019, to consider and approve Approval for Un-Audited Financial Results of the company for the quarter and half year ended on 30th September, 2019, apart from other business items.
The above information is a part of company’s filings submitted to BSE.